Silvercrest Asset Management Group Llc
Source: SEC Form 13F · as of Mar 2026Silvercrest Asset Management Group Llc holds 17 biotech & pharma companies tracked by BioSniper, totaling $92.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$92.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Vericel Corp (VCEL)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| VCELVericel Corp | 959,207 | $30.9M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 313,984 | $17.3M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 108,413 | $6.8M |
| KNSAKiniksa Pharmaceuticals International, plc | 114,289 | $5.5M |
| PTGXProtagonist Therapeutics, Inc | 47,931 | $5.1M |
| ZYMEZymeworks Inc. | 163,649 | $4.1M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 46,887 | $4.1M |
| GILDGILEAD SCIENCES, INC. | 25,960 | $3.6M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 10,429 | $3.5M |
| NUVBNuvation Bio Inc. | 724,383 | $3.1M |
| LENZLENZ Therapeutics, Inc. | 283,206 | $2.6M |
| BCYCBICYCLE THERAPEUTICS PLC | 428,684 | $2.0M |
| ARGXARGENX SE | 2,487 | $1.8M |
| RVMDREVOLUTION MEDICINES, INC. | 7,905 | $769K |
| IONSIONIS PHARMACEUTICALS INC | 7,053 | $530K |
| TVRDTvardi Therapeutics, Inc. | 101,034 | $321K |
| ALTAltimmune, Inc. | 103,500 | $319K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.